CIGARETTE SMOKING AND DIABETIC PERIPHERAL NEUROPATHY: A SYSTEMATIC REVIEW
Keywords:
Cigarette, Diabetes Mellitus, Peripheral Neuropathy, SmokingAbstract
It is common knowledge that smoking cigarettes is associated with a wide range of detrimental effects on one's health, including the development of a number of diseases and conditions that can manifest in any organ or system of the body. Diabetes can lead to a wide variety of microvascular problems, some of which include ulcers and amputations, dysfunctions in erectile function and autonomic function, and erectile dysfunction. DPN, or diabetic peripheral neuropathy, is a microvascular complication of diabetes that is part of a larger spectrum of diabetic problems. It is also known as distal symmetrical polyneuropathy or sensorimotor neuropathy. The most common of these problems is diabetes peripheral neuropathy (DPN), which affects approximately 30 percent of persons who have diabetes types. It is largely agreed upon that oxidative stress is the final mechanism that is accountable for the cellular damage seen in diabetic neuropathy. [Citation needed] [Citation needed] It is defined by high levels of persistent generation of reactive oxygen species (ROS), which can include ozone, superoxide, hydrogen peroxide, singlet oxygen, and organic peroxides in cells. ROS can also be produced when cells are exposed to persistently high quantities of singlet oxygen. The term "peroxidative stress" can also be used to refer to this condition. Although there is inconsistency in the relationship between diabetic peripheral neuropathy and smoking cigarettes, research that reveal an association between the two show that the prevalence of the condition is greater than 10%.
References
Jamal A, Phillips E, Gentzke AS, Homa DM, Babb SD, King BA, et al. Current cigarette smoking among adults— United States, 2016. Morb Mortal Wkly Rep. 2018;67(2):53. [2] Fishman JA, Grippi MA, Kotloff RM, et al. Fishman’s Pulmonary Disease and Disorders Fifth Edition. New York: Elsevier Saunder; 2016.
Fauci AS, Jameson JL, Kasper D, et al. Harrison’s Principles of Internal Medicine 19th Edition. New York: McGraw- Hill Education; 2018.
Kim SY, Sim S, Choi HG. Active , passive , and electronic cigarette smoking is associated with asthma in adolescents. Sci Rep. 2017;1–8.
Akbarzadeh A, Salehi A, Molavi Vardanjani H, Poustchi H, Gandomkar A, Fattahi MR, et al. Epidemiology of Adult Diabetes Mellitus and its Correlates in Pars Cohort Study in Southern Iran. Arch Iran Med. November 2019;22(11):633–9.
Sattar N, Sorensen T, Taylor AE, Morris R, Munafò MR. Smoking and diabetes risk: building a causal case with clinical implications. Lancet Diabetes Endocrinol. 2015;3(12):918–20.
Śliwińska-Mossoń M, Milnerowicz H. The impact of smoking on the development of diabetes and its complications. Diabetes Vasc Dis Res. 2017;14(4):265–76.
Maddatu J, Anderson-Baucum E, Evans-Molina C. Smoking and the risk of type 2 diabetes. Transl Res. 2017;184:101–7.
Cameron NE, Eaton SEM, Cotter MA, Tesfaye S. Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia. 2001;44(11):1973–88.
Tesfaye S, Stevens LK, Stephenson JM, Fuller JH, Plater M, Ionescu-Tirgoviste C, et al. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia. November 1996;39(11):1377–84.
Vinik AI, Park TS, Stansberry KB, Pittenger GL. Diabetic neuropathies. Diabetologia. Agustus 2000;43(8):957–73. [12] Dinh Le T, Phi Thi Nguyen N, Thanh Thi Tran H, Luong Cong T, Ho Thi Nguyen L, Do Nhu B, et al. Diabetic peripheral neuropathy associated with cardiovascular risk factors and glucagon-like peptide-1 concentrations among
newly diagnosed patients with type 2 diabetes mellitus. Diabetes, Metab Syndr Obes Targets Ther. 2022;35–44.
Al-Kaabi JM, Al Maskari F, Zoubeidi T, Abdulle A, Shah SM, Cragg P, et al. Prevalence and determinants of peripheral neuropathy in patients with type 2 diabetes attending a tertiary care center in the United Arab Emirates. J Diabetes Metab. 2014;5(346):2.
Al-Sarihin K, Althwabia I, Bani Khaled M, Haddad F. Prevalence of peripheral neuropathy among patients with diabetes mellitus at King Hussein Hospital, Amman, Jordan. Rawal Med J. 1 Januari 2013;38:92–6.
Bansal D, Gudala K, Muthyala H, Esam HP, Nayakallu R, Bhansali A. Prevalence and risk factors of development of peripheral diabetic neuropathy in type 2 diabetes mellitus in a tertiary care setting. J Diabetes Investig. November 2014;5(6):714–21.
Callaghan BC, Cheng HT, Stables CL, Smith AL, Feldman EL. Diabetic neuropathy: clinical manifestations and current treatments. lancet Neurol. 2012;11(6):521–34.
Said G. Diabetic neuropathy—a review. Nat Clin Pract Neurol. 2007;3(6):331–40.
Vincent AM, Russell JW, Low P, Feldman EL. Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr Rev. 2004;25(4):612–28.
Vincent AM, Callaghan BC, Smith AL, Feldman EL. Diabetic neuropathy: cellular mechanisms as therapeutic targets. Nat Rev Neurol. 2011;7(10):573–83.
Marwick TH, Ritchie R, Shaw JE, Kaye D. Implications of Underlying Mechanisms for the Recognition and Management of Diabetic Cardiomyopathy. J Am Coll Cardiol. Januari 2018;71(3):339–51.
Garbin U, Fratta Pasini A, Stranieri C, Cominacini M, Pasini A, Manfro S, et al. Cigarette smoking blocks the protective expression of Nrf2/ARE pathway in peripheral mononuclear cells of young heavy smokers favouring inflammation. PLoS One. 2009;4(12):e8225.
Choi S, Krishnan J, Ruckmani K. Cigarette smoke and related risk factors in neurological disorders: An update. Biomed Pharmacother. 2017;85:79–86.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing
Ninety Nine Publication publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
